Quadrivalent flu vaccine in prefilled syringes, federal excise tax and shipping. If quadrivalent flu vaccine is unavailable, will consider trivalent flu vaccine in prefilled syringes, federal excise…
Ended Awarded
- Contract number
- 15F06722F0000939
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Obligated
- $242,809
Award facts
- Contract value 100% obligated
- $242,808.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20535, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of quadrivalent flu vaccine in prefilled syringes, including federal excise tax and shipping, to the Department of Justice Federal Bureau of Investigation Headquarters Division. The contract has a potential value of $242,808.50 and is a firm fixed price delivery order issued to the prime contractor, Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract does not have a set-aside designation and is intended to support the agency's influenza prevention efforts, with a delivery due by September 30, 2022. Glaxosmithkline is a global pharmaceutical company that has provided a range of vaccine and antiviral products to multiple U.S. government agencies through various federal contract vehicles, including the Centers for Disease Control and Prevention and the Department of Defense.
Description
Quadrivalent flu vaccine in prefilled syringes, federal excise tax and shipping. If quadrivalent flu vaccine is unavailable, will consider trivalent flu vaccine in prefilled syringes, federal excise tax and shipping. Deliver mid september 2022 to all
Quick answers
Who was awarded contract 15F06722F0000939?
15F06722F0000939 was awarded to Glaxosmithkline, LLC by Headquarters Division (Federal Bureau of Investigation) on September 6, 2022.
How much is contract 15F06722F0000939 worth?
The government has obligated $242,809 on 15F06722F0000939.
Is contract 15F06722F0000939 an order under another contract?
Yes. 15F06722F0000939 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15F06722F0000939 competed?
The extent of competition for 15F06722F0000939 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award